Keros Therapeutics, Inc. (KROS)
11.68
-2.09
(-15.18%)
USD |
NASDAQ |
Mar 05, 14:54
Keros Therapeutics Cash from Investing (Quarterly) : -0.132M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -6.494M |
| MannKind Corp. | -291.96M |
| Sarepta Therapeutics, Inc. | 96.21M |
| Insmed, Inc. | 389.41M |
| Ionis Pharmaceuticals, Inc. | -419.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.249M |
| Cash from Financing (Quarterly) | 0.14M |
| Free Cash Flow | 87.08M |
| Free Cash Flow Per Share (Quarterly) | 0.0767 |
| Free Cash Flow to Equity (Quarterly) | 3.642M |
| Free Cash Flow to Firm (Quarterly) | 3.117M |
| Free Cash Flow Yield | 18.34% |